153 related articles for article (PubMed ID: 6453176)
21. [Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
Nagasaka T
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):757-66. PubMed ID: 6454322
[TBL] [Abstract][Full Text] [Related]
22. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
Szarvas Z; Zsolnai B
Acta Chir Hung; 1984; 25(4):269-76. PubMed ID: 6240879
[TBL] [Abstract][Full Text] [Related]
23. [A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
Takeda M; Kubo K; Fukushima M; Hirayama J; Sekiguchi M
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2113-7. PubMed ID: 2145808
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and cytological characteristics of endometrial cancer under radiation therapy].
Titova VA; Titova NP
Med Radiol (Mosk); 1981 May; 26(5):21-7. PubMed ID: 6165876
[No Abstract] [Full Text] [Related]
25. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
Lindahl B; Willén R
Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
[TBL] [Abstract][Full Text] [Related]
26. Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
Kauppila A; Vihko R
Acta Obstet Gynecol Scand; 1981; 60(6):589-90. PubMed ID: 6461159
[No Abstract] [Full Text] [Related]
27. High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.
Aabo K; Pedersen AG; Haid I; Dombernowsky P
Cancer Treat Rep; 1982 Feb; 66(2):407-8. PubMed ID: 6459846
[No Abstract] [Full Text] [Related]
28. [Medroxyprogesterone and endometrial adenocarcinoma].
Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
[No Abstract] [Full Text] [Related]
29. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
Bonte J; Drochmans A; Ide P
Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
[No Abstract] [Full Text] [Related]
30. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
Tatman JL; Freedman RS; Scott W; Atkinson EN
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
[TBL] [Abstract][Full Text] [Related]
31. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Cohen CJ; Deppe G; Bruckner HW
Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
33. The status of receptors in the management of endometrial cancer.
Richardson GS; MacLaughlin DT
Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
[No Abstract] [Full Text] [Related]
34. [Current status of drug treatment of endometrial carcinoma].
Schulz KD; Kaiser R
Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
[No Abstract] [Full Text] [Related]
35. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
Horger EO; Williamson HO; Hester LL
J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
[No Abstract] [Full Text] [Related]
36. [Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Dallenbach-Hellweg G
Gynakologe; 1988 Dec; 21(4):302-7. PubMed ID: 2974824
[No Abstract] [Full Text] [Related]
37. [Action of MAP in adenocarcinoma of the endometrium. Clinical results and ultrastructural and histochemical study].
Pullè C; Rigano A
Minerva Ginecol; 1981 Oct; 33(10):937-54. PubMed ID: 7031520
[No Abstract] [Full Text] [Related]
38. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
[No Abstract] [Full Text] [Related]
39. [Growth of endometrial cancer and hormone].
Kanoh H; Hosono T; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
Macdonald RR; Thorogood J; Mason MK
Br J Obstet Gynaecol; 1988 Feb; 95(2):166-74. PubMed ID: 2964861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
